Antidepressant prescribing for adult people with an intellectual disability living in England

David Branford, Rohit Shankar*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Downloads (Pure)

Abstract

The prescribing of psychotropic medications for people with an intellectual disability has changed. In many locations across England, antidepressants have become the most widely prescribed psychotropic. In the context of the current NHS England STOMP programme to reduce inappropriate psychotropic prescribing for people with intellectual disability, there is an urgent need to understand whether this change reflects evidence-based use of the medications involved. There has been little analysis into the benefits or problems associated with the change and whether it is of concern. This paper offers a variety of possible explanations and opportunities to improve clinical practice and policy.

Original languageEnglish
Pages (from-to)488-493
Number of pages6
JournalBritish Journal of Psychiatry
Volume221
Issue number2
DOIs
Publication statusPublished - 22 Aug 2022

ASJC Scopus subject areas

  • Psychiatry and Mental Health

Keywords

  • Antidepressants
  • developmental disorders
  • information technologies
  • intellectual disability
  • polypharmacy

Fingerprint

Dive into the research topics of 'Antidepressant prescribing for adult people with an intellectual disability living in England'. Together they form a unique fingerprint.

Cite this